AR111236A1 - Uso intradialítico de tiosulfato de sodio - Google Patents

Uso intradialítico de tiosulfato de sodio

Info

Publication number
AR111236A1
AR111236A1 ARP180100530A ARP180100530A AR111236A1 AR 111236 A1 AR111236 A1 AR 111236A1 AR P180100530 A ARP180100530 A AR P180100530A AR P180100530 A ARP180100530 A AR P180100530A AR 111236 A1 AR111236 A1 AR 111236A1
Authority
AR
Argentina
Prior art keywords
intradialitical
tiosulfate
sodium
sodium tiosulfate
methods
Prior art date
Application number
ARP180100530A
Other languages
English (en)
Inventor
Craig Sherman
Original Assignee
Hope Medical Entpr Inc Dba Hope Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hope Medical Entpr Inc Dba Hope Pharmaceuticals filed Critical Hope Medical Entpr Inc Dba Hope Pharmaceuticals
Publication of AR111236A1 publication Critical patent/AR111236A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

En la presente se proporcionan métodos para mantener niveles fisiológicos de tiosulfato en un sujeto que se somete a hemodiálisis. En la presente también se proporcionan métodos para administrar tiosulfato de sodio aceptable desde el punto de vista farmacéutico a un sujeto que se somete a hemodiálisis.
ARP180100530A 2017-03-08 2018-03-07 Uso intradialítico de tiosulfato de sodio AR111236A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762468871P 2017-03-08 2017-03-08

Publications (1)

Publication Number Publication Date
AR111236A1 true AR111236A1 (es) 2019-06-19

Family

ID=63446695

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100530A AR111236A1 (es) 2017-03-08 2018-03-07 Uso intradialítico de tiosulfato de sodio

Country Status (14)

Country Link
US (4) US10744156B2 (es)
EP (1) EP3592824B1 (es)
JP (2) JP7416622B2 (es)
KR (2) KR20240038813A (es)
AR (1) AR111236A1 (es)
AU (2) AU2018231072B2 (es)
BR (1) BR112019018646A2 (es)
CA (1) CA3055107A1 (es)
IL (3) IL268883B (es)
NZ (1) NZ756704A (es)
PH (1) PH12019501971A1 (es)
TW (2) TWI789378B (es)
WO (1) WO2018165108A1 (es)
ZA (1) ZA202105781B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018231072B2 (en) 2017-03-08 2024-04-04 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
MX2020013734A (es) 2018-07-03 2021-05-27 Fennec Pharmaceuticals Inc Formulaciones de tiosulfato de sodio anhidro.
US11850313B2 (en) * 2019-12-20 2023-12-26 The London Health Sciences Centre Research Inc. Method and compositions for protecting tissue
CN116573782B (zh) * 2023-04-03 2023-11-03 迁安市宏奥工贸有限公司 脱硫废液的处理方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3683583D1 (de) 1985-09-10 1992-03-05 Res Corp Technologies Inc Osmotische mittel fuer peritonealdialyse.
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
FI98538C (fi) * 1993-10-20 1997-07-10 Enso Gutzeit Oy Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
WO2001021233A1 (en) * 1999-09-22 2001-03-29 Advanced Renal Technologies High citrate dialysate and uses thereof
KR20030014208A (ko) * 2000-04-26 2003-02-15 오레곤 헬스 사이언시즈 유니버시티 티올계 화학보호제 화합물의 투여
JP4882054B2 (ja) 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
JP5564158B2 (ja) 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
WO2006001345A1 (ja) 2004-06-23 2006-01-05 Kyowa Hakko Kogyo Co., Ltd. Ｌ－リジン・クエン酸塩結晶
US20070154570A1 (en) 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US7834065B2 (en) 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
US20090304600A1 (en) * 2008-06-09 2009-12-10 Anupkumar Shetty Intradialytic administration of sodium thiosulfate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
US20120321724A1 (en) 2009-06-15 2012-12-20 Bryan Nathan S Method of Measuring and Monitoring In Vivo Nitrite Levels
US8496973B2 (en) 2009-07-08 2013-07-30 Hope Medical Enterprises, Inc. Sodium thiosulfate-containing pharmaceutical compositions
EP2806882B1 (en) 2012-01-23 2018-11-14 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to clostridium infections
US9629872B2 (en) * 2012-05-10 2017-04-25 Inserm (Institut National De La Sante Et De La Recherche Medicale) Sodium thiosulphate for the treatment of ectopic calcifications
JP5486069B1 (ja) * 2012-11-05 2014-05-07 旭 酒井 透析装置
US20140350097A1 (en) 2013-05-23 2014-11-27 Medinox,Inc. Treatment of hypotension associated with hemodialysis
US11193942B2 (en) * 2014-12-09 2021-12-07 Anna Villarreal Methods and devices for female health monitoring
AU2018231072B2 (en) 2017-03-08 2024-04-04 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
AU2018231016B2 (en) 2017-03-08 2024-03-07 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Intradialytic use of sodium nitrite

Also Published As

Publication number Publication date
IL302827A (en) 2023-07-01
JP7416622B2 (ja) 2024-01-17
IL295119B1 (en) 2023-06-01
US11779596B2 (en) 2023-10-10
WO2018165108A1 (en) 2018-09-13
TWI789378B (zh) 2023-01-11
US20200338120A1 (en) 2020-10-29
KR20240038813A (ko) 2024-03-25
AU2018231072B2 (en) 2024-04-04
IL295119A (en) 2022-09-01
ZA202105781B (en) 2023-05-31
KR20190129911A (ko) 2019-11-20
EP3592824A4 (en) 2020-12-23
BR112019018646A2 (pt) 2020-04-07
US20240100086A1 (en) 2024-03-28
US20180256639A1 (en) 2018-09-13
AU2018231072A1 (en) 2019-09-19
CA3055107A1 (en) 2018-09-13
US11116790B2 (en) 2021-09-14
TW201840343A (zh) 2018-11-16
JP2024045164A (ja) 2024-04-02
IL268883A (en) 2019-10-31
US20220031735A1 (en) 2022-02-03
KR102647836B1 (ko) 2024-03-15
IL302827B1 (en) 2024-06-01
US10744156B2 (en) 2020-08-18
AU2024203603A1 (en) 2024-06-20
IL268883B (en) 2022-09-01
TW202315650A (zh) 2023-04-16
EP3592824B1 (en) 2024-06-12
PH12019501971A1 (en) 2020-06-15
IL295119B2 (en) 2023-10-01
JP2020510680A (ja) 2020-04-09
EP3592824A1 (en) 2020-01-15
NZ756704A (en) 2022-07-01

Similar Documents

Publication Publication Date Title
AR111236A1 (es) Uso intradialítico de tiosulfato de sodio
DOP2019000005A (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2
CO2019005922A2 (es) Variantes de il-2 para el tratamiento de enfermedades autoinmunes
CO2017001994A2 (es) Compuestos activos hacia bromodominios
CR20160069A (es) Compuestos terapéuticamente activos y sus métodos de uso
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
CL2018003754A1 (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo.
SV2018005687A (es) Derivados de dihidroimidazopirazinona usados en el tratamiento del cancer
CR20160271A (es) Compuestos peptidométicos y sus conjugados de anticuerpo-fármaco
NI201500059A (es) Inhibidores de la tirosina-quinasa de bruton
PE20142363A1 (es) Usos y articulo de fabricacion que incluye el inhibidor de la dimerizacion de her2 pertuzumab
NI201500140A (es) Compuestos y composiciones terapéuticos
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
CY1121554T1 (el) Παραγωγο πυρανοχρωμενυλ-φαινολης, και φαρμακευτικη συνθεση για αγωγη μεταβολικου συνδρομου ή φλεγμονωδους παθησης
CL2016000008A1 (es) Tratamiento de lesiones inflamatorias de rosacea con ivermectina.
AR111374A1 (es) Uso de lik066 en pacientes con insuficiencia cardíaca
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
CL2017000682A1 (es) Compuestos novedosos de imidazopiridazina y su uso.
CO2020005919A2 (es) Compuestos y composiciones farmaceuticas de los mismos para usarse en el tratamiento de enfermedades fibroticas
PE20181332A1 (es) Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos
DOP2017000014A (es) Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
BR112016029012A2 (pt) método de tratamento de câncer de pulmão de células não pequenas e/ou câncer de pulmão de células pequenas usando compostos de tienotriazolodiazepina
ZA202208504B (en) Intradialytic use of sodium nitrite
BR112019009029A2 (pt) anticorpos anti-bag3 em combinação com inibidores do ponto de verificação imune para uso terapeutico